GC
SGNT

Guggenheim Capital’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Guggenheim Capital’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-77,215
Closed -$1.16M – 2975
2016
Q2 		$1.16M Sell
77,215
-57,644
-43% -$741K ﹤0.01% 1954
2016
Q1 		$1.64M Sell
134,859
-325
-0.2% -$4.56K 0.01% 1707
2015
Q4 		$2.15M Sell
135,184
-10,058
-7% -$158K 0.01% 1566
2015
Q3 		$2.23M Buy
145,242
+65,016
+81% +$1.41M 0.01% 1511
2015
Q2 		$1.95M Buy
+80,226
New +$1.92M ﹤0.01% 1795

Guggenheim Capital's SGNT Position: Q3 2016 in Review

Guggenheim Capital sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 77,215 shares — an estimated $1.16M sold.

Guggenheim Capital first reported a position in SGNT in Q2 2015 and held it in 5 quarters. The position peaked at $2.23M in Q3 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Guggenheim Capital reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Guggenheim Capital sold 77,215 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $1.16M.
  • Guggenheim Capital first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2015 and held it in 5 quarters.
  • Guggenheim Capital's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $2.23M in Q3 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Guggenheim Capital's 13F filing for Q3 2016, filed 15 Nov 2016.